Phage display enables machine learning discovery of cancer antigen–specific TCRs
Science Advances · 13.06.2025 · 11 (24)
DOI: 10.1126/sciadv.ads5589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 13.06.2025. Verfasst von Giancarlo Croce und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology UNIL CHUV, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Machine Learning, Receptors, Antigen, T-Cell, Antigens, Neoplasm, Peptide Library. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
T cells targeting epitopes in infectious diseases or cancer play a central role in spontaneous and therapy-induced immune responses. Epitope recognition is mediated by the binding of the T cell receptor (TCR), and TCRs recognizing clinically relevant epitopes are promising for T cell–based therapies. Starting from a TCR targeting the cancer-testis antigen NY-ESO-1 157–165 epitope, we built large phage display libraries of TCRs with randomized complementary determining region 3 of the β chain. The TCR libraries were panned against NY-ESO-1, which enabled us to collect thousands of epitope-specific TCR sequences. Leveraging these data, we trained a machine learning TCR-epitope interaction predictor and identified several epitope-specific TCRs from TCR repertoires. Cellular assays revealed that the predicted TCRs displayed activity toward NY-ESO-1 and no detectable cross-reactivity. Our work demonstrates how display technologies combined with TCR-epitope interaction predictors can effectively leverage large TCR repertoires for TCR discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology UNIL CHUV, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
- Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
- Agora Cancer Research Centre, Lausanne, Switzerland.
- Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland.
- Department of Oncology UNIL CHUV, Ludwig Institute for Cancer Research, University Hospital of Lausanne, Lausanne, Switzerland.
ORCID-Profile: Giancarlo Croce, Rachid Lani, Marta A S Perez, Michal Bassani-Sternberg, Vincent Zoete, Alexandre Harari, Michael Hebeisen, Steven M Dunn, David Gfeller
Zitieren
APA
Croce, G., Lani, R., Tardivon, D., Bobisse, S., de Tiani, M., Bragina, M., Perez, M. A. S., Michaux, J., Pak, H. S., Michel, A., Gehret, T., Schmidt, J., Guillame, P., Bassani-Sternberg, M., Zoete, V., Harari, A., Rufer, N., Hebeisen, M., Dunn, S. M., & Gfeller, D. (2025). Phage display enables machine learning discovery of cancer antigen–specific TCRs. Science Advances, 11(24). https://doi.org/10.1126/sciadv.ads5589
Vancouver
Croce G, Lani R, Tardivon D, Bobisse S, de Tiani M, Bragina M, et al. Phage display enables machine learning discovery of cancer antigen–specific TCRs. Science Advances. 2025;11(24). doi:10.1126/sciadv.ads5589
BibTeX
@article{Croce2025,
author = {Croce, Giancarlo and Lani, Rachid and Tardivon, Delphine and Bobisse, Sara and de Tiani, Mariastella and Bragina, Maiia and Perez, Marta A S and Michaux, Justine and Pak, Hui Song and Michel, Alexandra and Gehret, Talita and Schmidt, Julien and Guillame, Philippe and Bassani-Sternberg, Michal and Zoete, Vincent and Harari, Alexandre and Rufer, Nathalie and Hebeisen, Michael and Dunn, Steven M and Gfeller, David},
title = {Phage display enables machine learning discovery of cancer antigen–specific TCRs},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {24},
doi = {10.1126/sciadv.ads5589}
}
EUVIMED